Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNAP study of stopping nucleos(t)ide analogue therapy in chronic hepatitis B
NL-OMON50717Phase 4Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of entecavir and tenofovir in Chronic Hepatitis B (CHB), sponsored by Erasmus MC. Primary endpoint: Sustained response at week 48. Planned start May 2019; status: not yet recruiting.
02
Drugs
entecavirtenofovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NL-OMON50717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50717.